22nd Century Group, Inc.'s Goodrich Tobacco Company Grants Exclusive Distribution Rights for Very Low Nicotine Cigarette Brand in Benelux
4/16/2013 10:58:52 AM
More...
|
22nd Century Group, Inc. Announces U.S. Patent Issues for MPO Nicotine Biosynthesis Gene
4/3/2013 10:51:37 AM
More...
|
22nd Century Group, Inc. Investors Convert $1.7 Million of Notes Into Common Stock
2/7/2013 9:40:54 AM
More...
|
22nd Century Group, Inc. Closes $2.5 Million Private Placement
1/14/2013 9:00:30 AM
More...
|
22nd Century Group, Inc. Announces Allowance of U.S. Patent for MPO Nicotine Biosynthesis Gene
1/3/2013 9:02:02 AM
More...
|
Presentations at a Major International Forensics Meeting Highlight the Ability of 22nd Century Group, Inc.' Patented PCT Platform to Improve DNA Detection in Important Forensic Samples
10/19/2012 10:16:46 AM
More...
|
Chinese and Australian Patents Allowed for 22nd Century Group, Inc.’s NBB Nicotine Biosynthesis Gene
7/9/2012 10:08:54 AM
More...
|
22nd Century Group, Inc. Announces Initial Results of Smoking Cessation Trial
12/28/2011 6:29:53 AM
More...
|
22nd Century Group, Inc. Reports Third Quarter Financial Results
11/15/2011 7:57:33 AM
More...
|
22nd Century Group, Inc. Licenses X-22 to Pharmaceutical Subsidiary; New York Times Reports Company Delivers Government Research Cigarettes
10/31/2011 7:16:13 AM
More...
|
|